LLMpediaThe first transparent, open encyclopedia generated by LLMs

David Baker (scientist)

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: AAVP7A1 Hop 4
Expansion Funnel Raw 85 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted85
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
David Baker (scientist)
NameDavid Baker
Birth date1962
Birth placeSeattle, Washington
NationalityAmerican
FieldsBiochemistry, Biophysics, Computational Biology, Structural Biology
WorkplacesUniversity of Washington; Institute for Protein Design; Howard Hughes Medical Institute
Alma materUniversity of California, San Francisco; University of Washington; Harvard University
Doctoral advisorJohn Myer
Known forProtein design, Rosetta, de novo enzyme design, synthetic immunogens
AwardsBreakthrough Prize, Lasker–Koshland Special Achievement Award, Albany Medical Center Prize

David Baker (scientist)

David Baker is an American biochemist and computational biologist noted for pioneering methods in protein structure prediction and de novo protein design. He leads a multidisciplinary effort that integrates computational algorithms, experimental structural biology, and synthetic biology to design novel proteins with applications in therapeutics, diagnostics, and materials. Baker directs the Institute for Protein Design and holds faculty positions affiliated with the University of Washington and the Howard Hughes Medical Institute.

Early life and education

Baker was born in Seattle, Washington and attended local schools before enrolling at the University of Washington for undergraduate studies, where he encountered faculty influences including William J. Rutter and Alexander Rich. He pursued graduate education at the University of California, San Francisco and completed doctoral research with advisors and collaborators linked to laboratories such as those of Stephen C. Harrison and Richard Henderson at institutions including Harvard University. His postdoctoral fellowship included work in laboratories associated with Martin Karplus, Michael Levitt, and groups connected to the development of computational models at Columbia University and the Max Planck Society. During training he interacted with researchers from the MRC Laboratory of Molecular Biology, Scripps Research Institute, and the National Institutes of Health.

Academic and research career

Baker joined the faculty of the University of Washington where he established a laboratory that combined approaches from groups at California Institute of Technology, Massachusetts Institute of Technology, and Stanford University. He developed the Rosetta software in collaboration with colleagues from the Howard Hughes Medical Institute and collaborators tied to the European Molecular Biology Laboratory and the Broad Institute. Baker has held positions with the Institute for Protein Design and has worked alongside scientists from Genentech, Novartis, Pfizer, and academic partners at the University of California, Berkeley. He has supervised graduate students and postdocs who trained at places like Yale University, University of Chicago, and Johns Hopkins University. His laboratory integrates experimental platforms including cryo-electron microscopy at facilities such as the Cryo-EM Consortium and X-ray crystallography using beamlines at the Advanced Photon Source and the European Synchrotron Radiation Facility.

Contributions to protein design and computational biology

Baker is best known for leading the development of Rosetta, a suite of algorithms influenced by earlier computational frameworks from groups including Ken Dill and Jane Richardson. Rosetta unified ideas from statistical potentials pioneered by researchers at Columbia University and fragment assembly approaches used by teams at Duke University and the University of California, San Diego. Using Rosetta, Baker’s group achieved milestones such as successful de novo design of protein folds, design of novel enzymes building on principles from Daniel Tawfik and Frances Arnold, and design of self-assembling nanomaterials reminiscent of efforts at the Wyss Institute and MIT. His team demonstrated designed binders and immunogens applied to pathogens studied by researchers at the Centers for Disease Control and Prevention, World Health Organization, and vaccine groups at Imperial College London and University of Oxford.

Baker’s lab integrated machine learning advances contributed by groups at Google DeepMind, OpenAI, and University College London with Rosetta pipelines, paralleling breakthroughs such as those by John Jumper and Demis Hassabis. His work in de novo enzyme catalysis drew on catalytic design frameworks related to the achievements of Frances Arnold and experimental validation strategies used by laboratories at the Max Planck Institute and ETH Zurich. Baker fostered community initiatives like RosettaCommons that connected teams from Carnegie Mellon University, University of Pennsylvania, and McGill University to accelerate protein engineering applications in therapeutics, diagnostics, and materials science.

Awards and honors

Baker’s contributions have been recognized with major honors including the Breakthrough Prize in Life Sciences, the Lasker–Koshland Special Achievement Award in Medical Science, and the Albany Medical Center Prize. He has been elected to the National Academy of Sciences and the American Academy of Arts and Sciences, and received fellowships from the Howard Hughes Medical Institute and awards from the Gordon and Betty Moore Foundation. He has been honored by societies such as the Biophysical Society, the American Chemical Society, and received recognition from institutions like the Royal Society and the European Molecular Biology Organization.

Selected publications

- Baker D, et al. Landmark papers on Rosetta methodology published alongside collaborators from Nature, Science, and Cell journals, drawing on contributions from researchers at University of California, San Diego and Princeton University. - Papers describing de novo protein design and enzyme catalysis with experimental validation in journals of the American Association for the Advancement of Science and the National Academy of Sciences. - Publications on designed vaccines and protein nanomaterials in high-impact venues in collaboration with groups at University of Oxford, Imperial College London, and the Institut Pasteur. - Methodological papers integrating machine learning and structure prediction that reference work by teams at Google DeepMind, DeepMind, and University College London.

Personal life and outreach

Baker maintains collaborations across global centers such as Seoul National University, Tsinghua University, University of Tokyo, and industry partners including AbbVie and Regeneron Pharmaceuticals. He has advocated open-source science through initiatives connected to RosettaCommons and educational outreach with organizations including HHMI and the National Science Foundation. Baker participates in public communication platforms alongside peers like Eric Lander and Jennifer Doudna and contributes to community science projects that engage institutions such as the Smithsonian Institution and national laboratories including Argonne National Laboratory.

Category:Living people Category:American biochemists Category:Computational biologists